Categories: News

LINGLONG TIRE TIPS OFF NEW JOURNEY WITH CHICAGO BULLS

Partnership underscores Chicago Bulls’ global reach and resonance and reflects Linglong Tire’s efforts to continue growing sports marketing portfolio

- Advertisement -

CHICAGO, Nov. 26, 2025 /PRNewswire/ — On November 25, 2025, Linglong Tire announced a global partnership with the NBA’s world-renowned Chicago Bulls. This signing marks another significant move by Linglong Tire in the field of sports marketing and the Bulls’ advancement of their international growth strategy.

- Advertisement -

Following Linglong’s partnerships with Chelsea and Real Madrid, the deal with the Chicago Bulls deepens Linglong’s global strategic layout and expands its portfolio of collaborations with top-tier global sports brands.

- Advertisement -

The Bulls strive to connect with more global fans by creating legendary digital and in-person experiences while growing strategic brand partnerships. This spirit aligns with Linglong’s core brand philosophy of driving performance and technological breakthroughs, specifically in material science and structural design.

- Advertisement -

As a leading global tire maker, Linglong is committed to integrating innovative technology and excellent performance into every product. Whether for urban commuting or in rapidly changing driving conditions akin to an NBA game, Linglong provides confidence through strong grip, precise control, and quiet comfort.

- Advertisement -

The strategic cooperation with the Chicago Bulls is a key component of Linglong’s plan to grow its presence in the North American market. Linglong has established North American brands – Green Max, ATLAS and Evoluxx – that will also support this partnership. Looking ahead, with the development of the brand’s production base in Brazil advancing, Linglong is gradually establishing a supply chain network covering the Americas, laying a solid production foundation for localized operations and market penetration.

- Advertisement -

Linglong will support courtside branding and fan engagement initiatives, including presenting the team’s annual Lunar New Year game, when the Bulls celebrate the Year of the Horse on Feb. 19, 2026. From community basketball programs to offline technology experience tours, the Bulls and Linglong Tire will work together to connect with fans and users around the world who are passionate about basketball and the reliability, safety and innovation provided by high-quality tires.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2832422/image.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/linglong-tire-tips-off-new-journey-with-chicago-bulls-302626264.html

- Advertisement -

Recent Posts

Nikon Metrology Receives Frost & Sullivan’s 2026 Global Product Leadership Recognition for Excellence in Laser Radar BIW Inspection

Recognized for advancing high-precision, in-line dimensional inspection and enabling data-driven manufacturing transformation in automotive productionSAN…

41 minutes ago

GIGABYTE Opens COMPUTEX 2026 with ENTER INFINITY, Where AI, Gaming, and PC Innovation Unite

TAIPEI, June 2, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, today officially opened…

41 minutes ago

GIGABYTE Unveils Award-Winning AI Gaming Laptops and Revolutionary GiMATE Updates at COMPUTEX 2026

TAIPEI, June 2, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, unveiled its AI…

41 minutes ago

Stamus Networks Marks 10th Year Supporting NATO CCDCOE Cyber Defense Exercises

Company celebrates a decade of supporting the world's premier live-fire cyber defense exercises with expertise,…

2 hours ago

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogrens Disease at EULAR 2026

ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+…

4 hours ago

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Favorable safety and tolerability profile, with rapid onset of clinical activity and therapeutic effects observed…

4 hours ago